Dr. Maykin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Ave # 6d
Sfgh Ob Gyn
San Francisco, CA 94110Phone+1 415-476-5192
Education & Training
University of California (San Francisco)Residency, Obstetrics and Gynecology, 2015 - 2019
David Geffen School of Medicine at UCLAClass of 2015
Certifications & Licensure
HI State Medical License 2018 - 2026
CA State Medical License 2017 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Clinical Trials
- Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep Start of enrollment: 2017 Sep 27
- Furosemide vs. Placebo for Severe Antepartum Hypertension Start of enrollment: 2021 Jan 04
Publications & Presentations
PubMed
- 1 citationsFurosemide to lower antenatal severe hypertension: a randomized placebo-controlled trial.Melanie M Maykin, Elizabeth Mercer, Kevin M Saiki, Bliss Kaneshiro, Corrie B Miller
American Journal of Obstetrics & Gynecology MFM. 2024-04-01 - Discriminatory regulations on postpartum sterilization for Medicaid recipients propagate health inequities.Melanie M Maykin, Rachel A Pilliod, Erika F Werner
Lancet Regional Health. Americas. 2022-02-01 - Reply to the Letter to the Editor: Therapeutic rest in early labor unlikely to contribute to unplanned neonatal intensive care unit admissions.Melanie M. Maykin, Adam K. Lewkowitz
American Journal of Obstetrics & Gynecology MFM. 2021-06-25
Press Mentions
Why COVID Vaccines Are Likely Safe for Pregnant PeopleFebruary 2nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
